Advocacy Actions
Comments on Shanghai FDA's Trial Administrative Measures on Medical Representative Registration
Comments on Shanghai FDA's Trial Administrative Measures on Medical Representative Registration
Read moreComments to NPC on Anti-Unfair Competition Law (Second Draft for Review)
On September 22, 2017, the European Chamber submitted feedback received from members regarding the call for comments on the second review draft of revision on Anti-Unfair Competition Law issued by the National People’s Congress (NPC).
Read moreComments on CDE's Catalogue of Marketed Drugs in China (Draft for Comments)
European Chamber Pharmaceutical Working Group comments on CDE's Catalogue of Marketed Drugs in China (Draft for Comments)
Read moreComments on CFDA's Announcement on Relevant Issues on Generics Quality and Efficacy Consistency Evaluation
European Chamber Comments on CFDA's Announcement on Relevant Issues on Generics Quality and Efficacy Consistency Evaluation
Read moreComments on CFDA's Inspection Guidelines on Generics Quality and Efficacy Consistency Evaluation
European Chamber Comments on CFDA's Inspection Guidelines on Generics Quality and Efficacy Consistency Evaluation
Read moreLetter to Medical Insurance Department of MOHRSS on Drug Renaming in NRDL
Letter to Medical Insurance Department of MOHRSS on Drug Renaming in NRDL
Read moreComments on CFDA's Announcement 52, 53, 54, 55 on Encouraging Innovation in Pharmaceutical and Medical Devices
European Chamber Pharmaceutical Working Group submitted comments on CFDA's Announcement No. 52, 53, 54, 55 on encouraging innovation in pharmaceutical and medical device.
Read moreMeeting with Vice-Governor of Anhui Province on Healthcare Industry
European Chamber Pharmaceutical Working Group representatives met with Mr. Xie Guangxiang, Vice-Governor of Anhui Province on healthcare industry and healthcare reform.
Read moreComments on MEP's Administrative Regulations on Access to and Benefits Sharing on Biological Genetic Resources (Draft for Comments)
European Chamber Comments on MEP's Administrative Regulations on Access to and Benefits Sharing on Biological Genetic Resources (Draft for Comments)
Read moreComments on Anti-unfair Competition Law (Draft Revision)
The European Chamber submitted consolidated comments from member companies to the National People's Congress on Anti-unfair Competition Law (Draft Revision).
Read more